Michael Sapienza Highlights Colorectal Cancer Alliance’s Patient Voice Nomination
Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:
“At the Colorectal Cancer Alliance, we believe the most transformative change in health begins with the voices of those most affected: patients.
We are honored to be nominated for the Healio Disruptive Innovators Award in The Patient Voice category. This award, given in collaboration with the The Association of Black Gastroenterologists and Hepatologists (ABGH) , goes to a patient advocate or advocacy group that moved the needle on a disease with regard to discussion in the public sphere, better communication between patients and providers and/or advocacy for legislative or regulatory action. See the nominees her.
This recognition reflects the power of listening deeply, elevating real experiences, and driving actionable solutions shaped by the community we serve. Every voice matters. Every story sparks change.
Please vote for the Alliance by August 25 to win the The Patient Voice Award.”
More posts featuring Michael Sapienza on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023